Diagnostics, Radionucleotides, Contract Manufacturing
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
27
NCT04116164
Safety and Targeting of Anti-hk2 Antibody in mCRPC
Phase: Early Phase 1
Role: Lead Sponsor
Start: Sep 18, 2019
Completion: Jul 6, 2023
Loading map...